1. Home
  2. VALN vs CLMB Comparison

VALN vs CLMB Comparison

Compare VALN & CLMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • CLMB
  • Stock Information
  • Founded
  • VALN 2012
  • CLMB 1982
  • Country
  • VALN France
  • CLMB United States
  • Employees
  • VALN N/A
  • CLMB N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • CLMB Retail: Computer Software & Peripheral Equipment
  • Sector
  • VALN Health Care
  • CLMB Technology
  • Exchange
  • VALN Nasdaq
  • CLMB Nasdaq
  • Market Cap
  • VALN 510.7M
  • CLMB 457.3M
  • IPO Year
  • VALN 2021
  • CLMB N/A
  • Fundamental
  • Price
  • VALN $6.79
  • CLMB $106.47
  • Analyst Decision
  • VALN Strong Buy
  • CLMB Buy
  • Analyst Count
  • VALN 2
  • CLMB 1
  • Target Price
  • VALN $16.00
  • CLMB $136.00
  • AVG Volume (30 Days)
  • VALN 142.9K
  • CLMB 29.0K
  • Earning Date
  • VALN 05-06-2025
  • CLMB 04-30-2025
  • Dividend Yield
  • VALN N/A
  • CLMB 0.64%
  • EPS Growth
  • VALN N/A
  • CLMB 49.27
  • EPS
  • VALN N/A
  • CLMB 4.06
  • Revenue
  • VALN $175,564,758.00
  • CLMB $465,607,000.00
  • Revenue This Year
  • VALN $19.17
  • CLMB $7.10
  • Revenue Next Year
  • VALN $26.31
  • CLMB $8.00
  • P/E Ratio
  • VALN N/A
  • CLMB $26.22
  • Revenue Growth
  • VALN 10.32
  • CLMB 32.27
  • 52 Week Low
  • VALN $3.62
  • CLMB $49.70
  • 52 Week High
  • VALN $9.50
  • CLMB $145.00
  • Technical
  • Relative Strength Index (RSI)
  • VALN 50.63
  • CLMB 45.06
  • Support Level
  • VALN $6.54
  • CLMB $104.34
  • Resistance Level
  • VALN $7.30
  • CLMB $108.38
  • Average True Range (ATR)
  • VALN 0.48
  • CLMB 5.74
  • MACD
  • VALN 0.01
  • CLMB 0.73
  • Stochastic Oscillator
  • VALN 56.79
  • CLMB 74.48

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About CLMB Climb Global Solutions Inc.

Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The Company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.

Share on Social Networks: